Anti-angiogenic role of angiostatin during corneal wound healing

Experimental Eye Research

Volumn 78, Issue 3, 2004, Pages 579-589

  Gabison, Eric ^a   Chang, Jin Hong ^a   Hernández Quintela, Everardo ^a   Javier, Joel ^a   Lu, Paul C S ^a,c   Ye, Hongqing ^a   Kure, Tomoko ^a   Kato, Takuji ^a   Azar, Dimitri T ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Endothelial cell proliferation; Metalloproteinases; Plasminogen; Wound healing

Indexed keywords

ANGIOSTATIN; ANGIOSTATIN ANTIBODY; MATRIX METALLOPROTEINASE INHIBITOR; PLASMIN B CHAIN ANTIBODY; PLASMINOGEN; POLYCLONAL ANTIBODY; PROTEIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTERY ENDOTHELIUM; CELL ASSAY; CELL CULTURE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA NEOVASCULARIZATION; EPITHELIUM CELL; EXCIMER LASER; EXPERIMENT; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INCUBATION TIME; INJECTION; KERATECTOMY; KRINGLE DOMAIN; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION; PULMONARY ARTERY; RAT; REVIEW; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; WILD TYPE; WOUND HEALING;

EID: 0842310247     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.09.005     Document Type: Article

References (46)

1. Amano S., Rohan R., Kuroki M., Tolentino M., Adamis A.P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 39:1998;18-22.
2. Barouch F.C., Miyamoto K., Allport J.R., et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest. Ophthalmol. Vis. Sci. 41:2000;1153-1158.
3. Bugge T.H., Flick M.J., Daugherty C.C., Degen J.L. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9:1995;794-807.
4. Cao Y., Chen A., An S.S.A., et al. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272:1997;22924-22928.
5. Cao Y., Ji R.W., Davidson D., et al. Kringle domains of human angiostatin: characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271:1996;29461-29467.
6. Cao Y., O'Reilly M.S., Marshall B., Flynn E., Ji R.W., Folkman J. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101:1998;1055-1063.
7. Cornelius L.A., Nehring L.C., Harding E., et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161:1998;6845-6852.
8. Chang J.H., Gabison E.E., Kato T., Azar D.T. Corneal neovascularization. Curr. Opin. Ophthalmol. 12:2001;242-249.
9. Chen C.C., Chang J.H., Lee J.B., Javier J., Azar D.T. Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Invest. Ophthalmol. Vis. Sci. 43:2002;2593-2602.
10. Dawson D.W., Volpert O.V., Gillis P., et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 285:1999;245-248.
11. Drew A.F., Tucker H.L., Kombrinck K.W., Simon D.I., Bugge T.H., Degen J.L. Plasminogen is a critical determinant of vascular remodeling in mice. Circ. Res. 87:2000;133-139.
12. Dueñas Z., Torner L., Corbacho A.M., et al. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest. Ophthalmol. Vis. Sci. 40:1999;2498-2505.
13. Folberg R., Hendrix M.J.C., Maniotis A.J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol. 156:2000;361-381.
14. de Fraipont F., Nicholson A.C., Feige J.J., Van Meir E.G. Thrombospondins and tumor angiogenesis. Trends Mol. Med. 7:2001;401-407.
15. Kao W.W., Kao C.W., Kaufman A.H., et al. Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice. Invest. Ophthalmol. Vis. Sci. 39:1998;502-508.
16. Kato T., Chang J.H., Azar D.T. Expression of type XVIII collagen during wound healing of corneal incisions and keratectomy wounds. Invest. Ophthalmol. Vis. Sci. 44:2003;78-85.
17. Kato T., Kure T., Chang J.H., et al. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 508:2001;187-190.
18. Kisker O., Onizuka S., Banyard J., et al. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Cancer Res. 61:2001;7298-7304.
19. Kleiner D.E., Stetler-Stevenson W.G. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 43:1999;S42-S51.
20. Kure T., Kato T., Hernández-Quintela E., Ye H., et al. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest. Ophthalmol. Vis. Sci. 44:2003;137-144.
21. Kuwano M., Fukushi J., Okamoto M., et al. Angiogenesis factors. Intern. Med. 40:2001;565-572.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Lijnen H.R., Ugwu F., Bini A., Collen D. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry. 37:1998;4699-4702.
24. Lin H.C., Chang J.H., Jain S., et al. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest. Ophthalmol. Vis. Sci. 42:2001;2517-2524.
25. Lu H., Dhanabal M., Volk R., Waterman M.J.F., Ramchandran R., Knebelmann B., Segal M., Sukhatme V.P. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells. Biochem. Biophys. Res. Commun. 258:1999;668-673.
26. Lu P.C.S., Ye H., Maeda M., Azar D.T. Immunolocalization and gene expression of matrilysin during corneal wound healing. Invest. Ophthalmol. Vis. Sci. 40:1999;20-27.
27. Maeda M., Vanlandingham B.D., Ye H., Lu P.C.S., Azar D.T. Immunoconfocal localization of gelatinase B expressed by migrating intrastromal epithelial cells after deep annular excimer keratectomy. Curr. Eye Res. 17:1998;836-843.
28. Moromizato Y., Stechschulte S., Miyamoto K., et al. CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am. J. Pathol. 157:2000;1277-1281.
29. Moser T.L., Kenan D.J., Ashley T.A., et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc. Nat. Acad. Sci. USA. 98:2001;6656-6661.
30. Moser T.L., Stack M.S., Asplin I., et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Nat. Acad. Sci. USA. 96:1999;2811-2816.
31. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.
32. O'Reilly M.S., Holmgren L., Shing Y., et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:1994;315-328.
33. O'Reilly M.S., Pirie-Shepherd S., Lane W.S., Folkman J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science. 285:1999;1926-1928.
34. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neurooncol. 50:2000;1-15.
35. Patterson B.C., Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272:1997;28823-28825.
36. Sang Q.X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 8:1998;171-177.
37. Sodetz J.M., Castellino F.J. The mechanism of activation of rabbit plasminogen by urokinase. J. Biol. Chem. 250:1975;3041-3049.
38. Stechschulte S.U., Joussen A.M., von Recum H.A., et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest. Ophthalmol. Vis. Sci. 42:2001;1975-1979.
39. Tarui T., Majumdar M., Miles L.A., Ruf W., Takada Y. Plasmin-induced migration of endothelial cells: a potential target for the anti-angiogenic action of angiostatin. J. Biol. Chem. 277:2002;33564-33570.
40. Tarui T., Miles L.A., Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J. Biol. Chem. 276:2001;39562-39568.
41. Torres P.F., De Vos A.F., van der Gaag R., Martins B., Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp. Eye Res. 63:1996;453-461.
42. Wang H.U., Chen Z.F., Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:1998;741-753.
43. Yatoh S., Kawakami Y., Imai M., et al. Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat. Transplantation. 66:1998;1519-1524.
44. Ye H.Q., Azar D.T. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest. Ophthalmol. Vis. Sci. 39:1998;913-921.
45. Ye H.Q., Maeda M., Yu F.S.X., Azar D.T. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest. Ophthalmol. Vis. Sci. 41:2000;2894-2899.
46. Yokoyama Y., Dhanabal M., Griffioen A.W., Sukhatme V.P., Ramakrishnan S. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res. 60:2000;2190-2196.